Breast, Cervical, and Colorectal Cancer Screening Rates in Women Aged 45 to 64 Years
JAMA Network Open 10.1001/jamanetworkopen.2026.12976May 15, 2026 at 11:00 AM EDT
How is timely cancer screening use in women aged 45 to 64 years distributed across 3 routinely recommended screening tests (breast, cervical, and colorectal)?In this cross-sectional study, an estimated 17.9 million US women aged 45 to 64 years were due for at least 1 cancer screening test, most commonly colorectal cancer. Among those due for at least 1 screening test, nearly half were due for multiple tests.These findings suggest that interventions to address uptake of multiple cancer screening tests—either through addressing access and common barriers to screening or by bundling tests together—could be particularly beneficial for reducing cancer mortality in middle-aged women.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.